Advertising disclosure: we may earn a commission when you buy through links on this site. How we make money

HomeTrials › NCT07481305

Other · Not applicable · Opening soon

Lifestyle Change Implementation Research Network at PRC at UMass Chan

NCT07481305 · Sponsor: University of Massachusetts, Worcester

What this trial means for you

This study is opening soon at 1 US site. It's studying see the official record for glp - 1.

Who can joinAll sexes, 18 Years and older
Healthy volunteersNo — diagnosis required
What you'd takesee the official record
Study length~3 years overall
Planned participants220
TypeInterventional (you receive treatment)

What participants typically get: study medication (or placebo, if the trial uses one) and study-related medical care at no cost, plus close monitoring. Compensation for time and travel varies by study — ask the site. Note that in many trials you can't choose your treatment group, and some participants receive a placebo.

The study, in the sponsor's words

The goal of this project is to study how well the Noom digital lifestyle program works for adults who are taking Glucagon-Like Peptide-1 receptor agonist (GLP-1) medications. The study team will assess how the program affects people's behaviors and health outcomes. The team will also look at how digital lifestyle change interventions can be implemented in real-world settings, including how many people it reaches, how well it is put into practice, whether people stick with it over time, and whether it works well for different groups of people.

Can you join? The exact criteria

Below is the verbatim eligibility text from the registry — bring it to your doctor; it's written for clinicians, and your own clinician is the right person to interpret it with you.

Full eligibility criteria (for you and your doctor)

Inclusion Criteria: 1. Began using a GLP-1 within the past 6 months 2. Currently using GLP-1 3. Plans to continue GLP-1 use 4. GLP-1 prescribed by their physician (e.g., not online or 3rd party vendor) 5. BMI ≥27 kg/m2 6. Age 18 years of age and older 7. Speaks and reads English or Spanish 8. Willing to enroll in a digital lifestyle intervention for 4-months 9. Willing to wear a Fitbit for 8 months Exclusion Criteria: 1. Not currently taking GLP-1 2. Under 18 years of age 3. BMI \<27 kg/m2 4. Began using GLP-1 more than 6 months ago 5. Does not speak or read English or Spanish 6. Not willing to follow study procedures, including digital LCI enrollment 7. Currently pregnant 8. Does not consent

Study sites by state

Massachusetts

  • UMass Chan Medical School — Worcester

View the official record on ClinicalTrials.gov →

Verify before you act. Medical disclaimer: content on this site is for informational purposes only and is not medical advice. GLP-1 medications are prescription drugs; always consult a licensed healthcare provider about eligibility, risks, and benefits. Trial details and enrollment status change frequently — always verify on the official registry and talk to your own clinician before contacting a study site. This page was generated from registry data and is not affiliated with the study sponsor.

Follow this trial

Get an email when our monthly digest covers enrollment changes and results for trials like this one.

Newsletter signup launches soon. (Site owner: set PUBLIC_BUTTONDOWN_USERNAME in .env to activate this form.)

Keep researching on StudyBackedHealth